These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31840427)

  • 1. Advances in imaging strategies for in vivo tracking of exosomes.
    Betzer O; Barnoy E; Sadan T; Elbaz I; Braverman C; Liu Z; Popovtzer R
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1594. PubMed ID: 31840427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post isolation modification of exosomes for nanomedicine applications.
    Hood JL
    Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging strategies for labeling and tracking of extracellular vesicles.
    Li YJ; Wu JY; Wang JM; Hu XB; Xiang DX
    J Control Release; 2020 Dec; 328():141-159. PubMed ID: 32882270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Exosomes as Theranostic Platforms for Cancer Treatment.
    Yang X; Xie X; Liu S; Ma W; Zheng Z; Wei H; Yu CY
    ACS Biomater Sci Eng; 2023 Oct; 9(10):5479-5503. PubMed ID: 37695590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate.
    Shao J; Zaro J; Shen Y
    Int J Nanomedicine; 2020; 15():9355-9371. PubMed ID: 33262592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles.
    Betzer O; Perets N; Angel A; Motiei M; Sadan T; Yadid G; Offen D; Popovtzer R
    ACS Nano; 2017 Nov; 11(11):10883-10893. PubMed ID: 28960957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease.
    Li DF; Yang MF; Xu J; Xu HM; Zhu MZ; Liang YJ; Zhang Y; Tian CM; Nie YQ; Shi RY; Wang LS; Yao J
    Int J Nanomedicine; 2022; 17():3893-3911. PubMed ID: 36092245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution of Exosomes and Engineering Strategies for Targeted Delivery of Therapeutic Exosomes.
    Choi H; Choi Y; Yim HY; Mirzaaghasi A; Yoo JK; Choi C
    Tissue Eng Regen Med; 2021 Aug; 18(4):499-511. PubMed ID: 34260047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.
    Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L
    Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies.
    García-Fernández J; Fuente Freire M
    Cancer Lett; 2023 May; 561():216151. PubMed ID: 37001751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial exosomes for translational nanomedicine.
    Li YJ; Wu JY; Liu J; Xu W; Qiu X; Huang S; Hu XB; Xiang DX
    J Nanobiotechnology; 2021 Aug; 19(1):242. PubMed ID: 34384440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of exosome-based cell-free strategies to enhance endogenous cell functions in tissue regeneration.
    Deng S; Cao H; Cui X; Fan Y; Wang Q; Zhang X
    Acta Biomater; 2023 Nov; 171():68-84. PubMed ID: 37730080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome Biochemistry and Advanced Nanotechnology for Next-Generation Theranostic Platforms.
    Yang B; Chen Y; Shi J
    Adv Mater; 2019 Jan; 31(2):e1802896. PubMed ID: 30126052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionalized DNA Enables Programming Exosomes/Vesicles for Tumor Imaging and Therapy.
    Fan Z; Xiao K; Lin J; Liao Y; Huang X
    Small; 2019 Nov; 15(47):e1903761. PubMed ID: 31614072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane Radiolabelling of Exosomes for Comparative Biodistribution Analysis in Immunocompetent and Immunodeficient Mice - A Novel and Universal Approach.
    Faruqu FN; Wang JT; Xu L; McNickle L; Chong EM; Walters A; Gurney M; Clayton A; Smyth LA; Hider R; Sosabowski J; Al-Jamal KT
    Theranostics; 2019; 9(6):1666-1682. PubMed ID: 31037130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome mimetics: a novel class of drug delivery systems.
    Kooijmans SA; Vader P; van Dommelen SM; van Solinge WW; Schiffelers RM
    Int J Nanomedicine; 2012; 7():1525-41. PubMed ID: 22619510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).
    Ke W; Afonin KA
    Adv Drug Deliv Rev; 2021 Sep; 176():113835. PubMed ID: 34144087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.